Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in women will increase the incidence of female sexual dysfunctions. This will provide considerable growth opportunities to market participants.
Mental health conditions such as depression are being recognized as critical health issues mostly among women. As a result, many pharmaceutical companies are releasing drugs and therapies to treat these conditions leading to an increase in the consumption of antidepressants, antipsychotics, and antiepileptics. Moreover, there is also an increase in the consumption of contraceptives. These drugs cause sexual dysfunctions in women.
In 2018, the global Female Sexual Dysfunction Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
AMAG Pharmaceuticals Inc.
Duchesnay Inc.
Emotional Brain BV
Novo Nordisk AS
Sprout Pharmaceuticals Inc.
...
Market segment by Type, the product can be split into
Non-hormonal Therapy
Hormonal Therapy
Market segment by Application, split into
Sexual Desire Disorders
Sexual Arousal Disorders
Orgasm Disorders
Sexual Pain Disorders
Post-orgasmic Diseases
Pelvic Floor Dysfunction
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players.
To present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Female Sexual Dysfunction Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Female Sexual Dysfunction Treatment. Industry analysis & Market Report on Female Sexual Dysfunction Treatment is a syndicated market report, published as Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Female Sexual Dysfunction Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.